WHO ICTRP trial
Multi center clinical study to evaluate the safety and efficacy of CB-03-01 for…
EUCTR2019-000950-78-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2019-000950-78-DE |
|---|---|
| Public title | Multi center clinical study to evaluate the safety and efficacy of CB-03-01 for the treatment of female pattern hair loss, versus Minoxidil and placebo at different dosage of CB-03-01 |
| Scientific title | A Phase 2, multicenter, prospective, randomized, double-blind, Minoxidil and vehicle controlled, dose-ranging study to evaluate the efficacy and safety of CB-03-01 (Cortexolone 17a-propionate) solution for the treatment of androgenetic alopecia in females - NA |
| Primary sponsor | Cassiopea S.p.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | Female Androgenic Alopecia (AGA) is scalp hair loss that occurs due to an underlying susceptibility of hair follicles to androgenic miniaturization. In the hair follicle, testosterone is converted by 5a-reductase into 5a-dihydrotestosterone… |
| Interventions | Product Name: Cortexolone 17a-propionate solution 5% Product Code: CB-03-01 solution 5% Pharmaceutical Form: Cutaneous solution INN or Proposed INN: Cortexolone 17a-propionate CAS Number: 19608-29-8 Current Sponsor code: CB-03-01 Other… |
| Registration date | Apr 30, 2019 |
| Target size | 280 |
| Secondary IDs | CB-03-01/35 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: